Fasting serum lipids and serum lipoprotein distribution during oral contraceptive therapy in Nigerians.
D002784:Cholesterol / Q000097:blood; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000494:pharmacology*; D004952:Esters / Q000097:blood; D004958:Estradiol / Q000008:administration & dosage; D005215:Fasting; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood*; D008656:Mestranol / Q000008:administration & dosage; D009549:Nigeria; D009640:Norethindrone / Q000008:administration & dosage; D009644:Norgestrel / Q000008:administration & dosage; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D003276:Contraceptives, Oral; D004952:Esters; D008055:Lipids; D008074:Lipoproteins; D014280:Triglycerides; D009644:Norgestrel; D004958:Estradiol; D002784:Cholesterol; D008656:Mestranol; D009640:Norethindrone